TNFRSF13C Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q96RJ3 |
---|---|
Clone Names | 100430317 |
Gene ID | 115650 |
---|---|
Other Names | Tumor necrosis factor receptor superfamily member 13C, B-cell-activating factor receptor, BAFF receptor, BAFF-R, BLyS receptor 3, CD268, TNFRSF13C, BAFFR, BR3 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP14039a was selected from the N-term region of TNFRSF13C. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TNFRSF13C |
---|---|
Synonyms | BAFFR, BR3 |
Function | B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response. |
Cellular Location | Membrane; Single-pass type III membrane protein |
Tissue Location | Highly expressed in spleen and lymph node, and in resting B-cells. Detected at lower levels in activated B-cells, resting CD4+ T-cells, in thymus and peripheral blood leukocytes |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
B cell-activating factor (BAFF) enhances B-cell survivalin vitro and is a regulator of the peripheral B-cell population.Overexpression of Baff in mice results in mature B-cell hyperplasiaand symptoms of systemic lupus erythematosus (SLE). Also, some SLEpatients have increased levels of BAFF in serum. Therefore, it hasbeen proposed that abnormally high levels of BAFF may contribute tothe pathogenesis of autoimmune diseases by enhancing the survivalof autoreactive B cells. The protein encoded by this gene is areceptor for BAFF and is a type III transmembrane proteincontaining a single extracellular cysteine-rich domain. It isthought that this receptor is the principal receptor required forBAFF-mediated mature B-cell survival.
References
Mihalcik, S.A., et al. J. Immunol. 185(2):1045-1054(2010)Parameswaran, R., et al. Cancer Res. 70(11):4346-4356(2010)Davila, S., et al. Genes Immun. 11(3):232-238(2010)Yuan, H., et al. DNA Cell Biol. 29(3):133-139(2010)Yuan, H.X., et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26(2):111-114(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.